Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gradual Cessation of Proton Pump Inhibitor (PPI) Treatment May Prevent Rebound Acid Secretion in Dyspeptic and Reflux Patients, Measured by the Alkaline Tide Method.

NCT01315444 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT01315444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01315444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gradual Cessation of Proton Pump Inhibitor (PPI) Treatment May Prevent Rebound Acid Secretion in Dyspeptic and Reflux Patients, Measured by the Alkaline Tide Method.
Lead sponsor
Rabin Medical Center
Phase
Phase 1
Overall status
Withdrawn
Start date
December 31, 2014
Completion date
December 31, 2016
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

condition measuring alkaline tide and filling symptoms' questionnaire after abrupt or gradual step down cessation of ppi